Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma

Annals of Surgical Oncology

Volumn 19, Issue 3, 2012, Pages 973-980

  Buitrago, D ^a   Keutgen, X M ^a   Crowley, M ^a   Filicori, F ^a   Aldailami, H ^a   Hoda, R ^a   Liu, Yi Fang ^a   Hoda, R S ^a   Scognamiglio, T ^a   Jin, M ^b   Fahey III, T J ^a   Zarnegar, R ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b Cornell University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; COMPLEMENTARY RNA; INTERCELLULAR ADHESION MOLECULE 1; RNA; B RAF KINASE; BRAF PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; THYROID CARCINOMA; THYROID HYPERPLASIA; THYROID PAPILLARY CARCINOMA; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; MUTATION; PAPILLARY CARCINOMA; PATHOLOGY; PROTEIN MICROARRAY; REAL TIME POLYMERASE CHAIN REACTION; THYROID TUMOR; UPREGULATION;

ADOLESCENT; ADULT; AGED; CARCINOMA, PAPILLARY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HASHIMOTO DISEASE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUTATION; PROTEIN ARRAY ANALYSIS; PROTO-ONCOGENE PROTEINS B-RAF; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROID NEOPLASMS; UP-REGULATION; YOUNG ADULT;

EID: 84862247454     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2029-0     Document Type: Article

References (28)

1. Rivera M, Ghossein RA, Schoder H, et al. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucosepositron emission tomography-positive thyroid carcinoma. Cancer. 2008;113:48-56. (Pubitemid 351976385)
2. Yang L, Froio RM, Sciuto TE, et al. ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow. Blood. 2005;106:584-92. (Pubitemid 40981255)
3. Hayes SH, Seigel GM. Immunoreactivity of ICAM-1 in human tumors, metastases and normal tissues. Int J Clin Exp Pathol. 2009;2:553-60.
4. Nakashima M, Eguchi K, Ishikawa N, et al. Expression of adhesion molecule ICAM-1 (CD54) in thyroid papillary adenocarcinoma. J Endocrinol Invest. 1994;17:843-8.
5. Lin YC, Shun CT, Wu MS, Chen CC. A novel anticancer effect of thalidomide: inhibition of intercellular adhesion molecule-1- mediated cell invasion and metastasis through suppression of nuclear factor-kappaB. Clin Cancer Res. 2006;12:7165-73.
6. Skelding KA, Barry RD, Shafren DR. Systemic targeting of metastatic human breast tumor xenografts by Coxsackievirus A21. Breast Cancer Res Treat. 2009;113:21-30.
7. Basoglu M, Atamanalp SS, Yildirgan MI, et al. Correlation between the serum values of soluble intercellular adhesion molecule- 1 and total sialic acid levels in patients with breast cancer. Eur Surg Res. 2007;39:136-40. (Pubitemid 46633174)
8. Pasieka Z, Kuzdak K, Czyz W, et al. Soluble intracellular adhesion molecules (sICAM-1, sVCAM-1) in peripheral blood of patients with thyroid cancer. Neoplasma. 2004;51:34-7. (Pubitemid 38250154)
9. Melis M, Spatafora M, Melodia A, et al. ICAM-1 expression by lung cancer cell lines: effects of upregulation by cytokines on the interaction with LAK cells. Eur Respir J. 1996;9:1831-8. (Pubitemid 26294752)
10. Park S, Kang S, Veach AJ, et al. Self-assembled nanoplatform for targeted delivery of chemotherapy agents via affinity-regulated molecular interactions. Biomaterials. 2010;31:7766-75.
11. Arora N, Scognamiglio T, Lubitz CC, et al. Identification of borderline thyroid tumors by gene expression array analysis. Cancer. 2009;115:5421-31.
12. Pfeiffer P, Nexo E, Bentzen SM, et al. Enzyme-linked immunosorbent assay of epidermal growth factor receptor in lung cancer: comparisons with immunohistochemistry, clinicopathological features and prognosis. Br J Cancer. 1998;78:96-9. (Pubitemid 28276776)
13. Tanda F, Cossu A, Bosincu L, et al. Intercellular adhesion molecule- 1 (ICAM-1) immunoreactivity in well-differentiated thyroid papillary carcinomas. Mod Pathol. 1996;9:53-6. (Pubitemid 26061127)
14. Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid Off J Am Thyroid Assoc. 2006;16: 109-42.
15. Andersen PE, Kinsella J, Loree TR, et al. Differentiated carcinoma of the thyroid with extrathyroidal extension. Am J Surg. 1995;170:467-70.
16. Mazzaferri EL. Papillary thyroid carcinoma: factors influencing prognosis and current therapy. Semin Oncol. 1987;14:315-32.
17. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 1988;104:947-53. (Pubitemid 19011971)
18. Arora N, Turbendian HK, Scognamiglio T, et al. Extrathyroidal extension is not all equal: implications of macroscopic versus microscopic extent in papillary thyroid carcinoma. Surgery. 2008;144:942-7 (discussion 947-8).
19. Pfister DG, Fagin JA. Refractory thyroid cancer: a paradigm shift in treatment is not far off. J Clin Oncol. 2008;26:4701-4.
20. Ricarte-Filho JC, Ryder M, Chitale DA, et al. Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1. Cancer Res. 2009;69:4885-93.
21. Xing M. BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocr Rev. 2007;28:742-62. (Pubitemid 350294294)
22. Riesco-Eizaguirre G, Rodriguez I, De la Vieja A, et al. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer. Cancer Res. 2009;69: 8317-25.
23. Derhaag JG, Duijvestijn AM, Van Breda Vriesman PJ. Heart EC respond heterogeneous on cytokine stimulation in ICAM-1 and VCAM-1, but not in MHC expression. A study with 3 rat heart endothelial cell (RHEC) lines. Endothel J Endothel Cell Res. 1997;5:307-19. (Pubitemid 28177015)
24. Murakami T, Mataki C, Nagao C, et al. The gene expression profile of human umbilical vein endothelial cells stimulated by tumor necrosis factor alpha using DNA microarray analysis. J Atheroscler Thromb. 2000;7:39-44.
25. Hu G, Gong AY, Liu J, et al. miR-221 suppresses ICAM-1 translation and regulates interferon-gamma-induced ICAM-1 expression in human cholangiocytes. Am J Physiol Gastrointest Liver Physiol. 2010;298:G542-50.
26. Ueda R, Kohanbash G, Sasaki K, et al. Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1. Proc Natl Acad Sci USA. 2009;106:10746-51.
27. Lin FS, Lin CC, Chien CS, et al. Involvement of p42/p44 MAPK, JNK, and NF-kappaB in IL-1beta-induced ICAM-1 expression in human pulmonary epithelial cells. J Cell Physiol. 2005;202: 464-73.
28. Yan W, Jiang Y, Huang Q. [The role of p38 MAPK in LPS induced ICAM-1 expression on endothelial cell]. Zhonghua shao shang za zhi (Chin J Burns). 2001;17:32-5.